| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 8.605 | 27.770 | 80.542 | 85.735 | 88.656 | 113.972 |
| Total Income - EUR | - | - | - | - | 8.605 | 27.770 | 80.542 | 85.780 | 88.656 | 113.972 |
| Total Expenses - EUR | - | - | - | - | 22.984 | 51.257 | 77.949 | 55.123 | 70.739 | 93.697 |
| Gross Profit/Loss - EUR | - | - | - | - | -14.379 | -23.487 | 2.593 | 30.657 | 17.917 | 20.275 |
| Net Profit/Loss - EUR | - | - | - | - | -14.379 | -23.765 | 1.788 | 29.799 | 17.048 | 16.924 |
| Employees | - | - | - | - | 5 | 9 | 7 | 7 | 4 | 7 |
Check the financial reports for the company - Miracol Therapy S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 670 | 587 | 1.162 | 1.509 |
| Current Assets | - | - | - | - | 421 | 175 | 8.499 | 30.075 | 38.343 | 37.448 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 365 | 0 | 1.969 | 2.506 | 19.774 | 26.846 |
| Cash | - | - | - | - | 57 | 175 | 6.530 | 27.569 | 18.569 | 10.602 |
| Shareholders Funds | - | - | - | - | -14.337 | -37.829 | -35.109 | -5.418 | 11.646 | 11.570 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 14.758 | 38.005 | 44.278 | 36.080 | 27.859 | 27.388 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8699 - 8699" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Miracol Therapy S.r.l.